Gestational Diabetes Mellitus from Inactivation of Prolactin Receptor and Mafb in Islet B-Cells

Total Page:16

File Type:pdf, Size:1020Kb

Gestational Diabetes Mellitus from Inactivation of Prolactin Receptor and Mafb in Islet B-Cells Diabetes Volume 65, August 2016 2331 Ronadip R. Banerjee,1,2 Holly A. Cyphert,3 Emily M. Walker,3 Harini Chakravarthy,1 Heshan Peiris,1 Xueying Gu,1 Yinghua Liu,1 Elizabeth Conrad,3 Lisa Goodrich,4 Roland W. Stein,3 and Seung K. Kim1,5,6 Gestational Diabetes Mellitus From Inactivation of Prolactin Receptor and MafB in Islet b-Cells Diabetes 2016;65:2331–2341 | DOI: 10.2337/db15-1527 b-Cell proliferation and expansion during pregnancy through enhanced insulin secretion and by b-cell prolifera- are crucial for maintaining euglycemia in response to in- tion and expansion in mice (1). Failure of adaptive b-cell creased metabolic demands placed on the mother. Pro- expansion underlies dysregulated glucose homeostasis and lactin and placental lactogen signal through the prolactin progression to diabetes mellitus (2). Thus, the mechanisms receptor (PRLR) and contribute to adaptive b-cell re- underlying gestational b-cell proliferation are a focus of in- sponses in pregnancy; however, the in vivo requirement tensive ongoing investigation. fi b for PRLR signaling speci cally in maternal -cell adapta- Pregnancy hormones are known regulators of b-cell tions remains unknown. We generated a floxed allele of growth and function (3). The lactogenic hormones prolactin ISLET STUDIES Prlr b , allowing conditional loss of PRLR in -cells. In this and placental lactogen signal through the prolactin receptor study, we show that loss of PRLR signaling in b-cells re- (PRLR) and are crucial regulators of pregnancy adaptation in sults in gestational diabetes mellitus (GDM), reduced b-cell b many maternal tissues (4). PRLR is expressed in both rodent proliferation, and failure to expand -cell mass during preg- b b and human pancreatic -cells (5), and in vitro treatment of nancy. Targeted PRLR loss in maternal -cells in vivo im- b paired expression of the transcription factor Foxm1,both islets with prolactin has established it as a potent -cell mi- G /S and G /M cyclins, tryptophan hydroxylase 1 (Tph1), togen in both species (1). Although gene expression studies of 1 2 fi and islet serotonin production, for which synthesis requires islets during pregnancy identi ed strong induction of some – Tph1. This conditional system also revealed that PRLR sig- prolactin signaling targets (6 8), the mechanisms underlying b naling is required for the transient gestational expression of lactogen-stimulated changes in -cells during pregnancy are the transcription factor MafB within a subset of b-cells incompletely understood. During transient b-cell proliferation during pregnancy. MafB deletion in maternal b-cells also and expansion during gestation, prior studies have reported produced GDM, with inadequate b-cell expansion accom- increased expression of nuclear factors like FoxM1, the cyclin- panied by failure to induce PRLR-dependent target genes dependent kinases cyclin A2 and cyclin B1, and MafB (6,9,10). regulating b-cell proliferation. These results unveil molec- However, the requirement for PRLR signaling to induce ex- ular roles for PRLR signaling in orchestrating the physio- pression of these factors and the physiologic significance of logic expansion of maternal b-cells during pregnancy. the gestational MafB+ b-cell subpopulation are unknown. Studies of b-cells during pregnancy in humans are con- founded by practical and ethical challenges. Thus, animal Pregnancy is a unique acquired physiologic state of increased studies remain critical for understanding b-cell biology dur- metabolic demand, requiring increased output of insulin by ing pregnancy (11). Mouse genetic studies of PRLR support islet b-cells. This adaptive response is accomplished both aroleinb-cell development and function; the global PRLR 1Department of Developmental Biology, Stanford University School of Medicine, Corresponding author: Seung K. Kim, [email protected]. Stanford, CA Received 4 November 2015 and accepted 11 May 2016. 2Division of Endocrinology, Gerontology and Metabolism, Department of Medi- This article contains Supplementary Data online at http://diabetes cine, Stanford University School of Medicine, Stanford, CA .diabetesjournals.org/lookup/suppl/doi:10.2337/db15-1527/-/DC1. 3Department of Molecular Physiology and Biophysics, Vanderbilt University, Nashville, TN © 2016 by the American Diabetes Association. Readers may use this article as 4Department of Neurobiology, Harvard Medical School, Boston, MA long as the work is properly cited, the use is educational and not for profit, and 5Division of Oncology, Department of Medicine, Stanford University School of the work is not altered. Medicine, Stanford, CA 6Howard Hughes Medical Institute, Stanford University School of Medicine, Stan- ford, CA 2332 b-Cell PRLR KO and Gestational Diabetes Mellitus Diabetes Volume 65, August 2016 knockout has glucose intolerance and reduced b-cell mass Laboratory Animal Care or Vanderbilt Animal Care and (12). Unfortunately, the global Prlr knockout mouse is ster- Use Program. Prlr+/2 ile, precluding pregnancy studies (13). mice studied Tolerance Testing and Serum Metabolite Analysis during pregnancy develop glucose intolerance and reduction Intraperitoneal glucose and insulin tolerance testing were in b-cell proliferation and mass expansion (14). Neverthe- performed as previously described (19). An oral glucose less, as loss of PRLR results in multiple abnormalities in tolerance test (GTT) was performed using a 22-gauge rigid other metabolic tissues that could indirectly influence b-cell gavage needle to deliver an intragastric glucose bolus of function (15), it is essential to assess the consequences of fi b 2 g/kg body weight. Blood was collected by tail vein bleed- targeted PRLR inactivation speci cally in -cells. In this ing. Blood glucose levels were determined by glucometer study, we generated a conditional Prlr allele allowing Cre (Bayer Contour; Bayer). Ad libitum fed or overnight (16 h)– recombinase–mediated genetic ablation of PRLR signaling fasted blood glucose levels were measured at 8:30 A.M.Se- and identified a requirement for PRLR in molecular, hor- rum insulin levels were performed by ELISA (Crystal Chem) monal, and proliferative adaptations by maternal b-cells following the manufacturer’sdirections. in pregnancy. Collectively, our results suggest PRLR sig- naling is a master regulator of adaptive b-cell responses Islet Isolation and Culture during pregnancy. Islets were isolated using retrograde perfusion of the pancreatic duct with collagenase, purified using density RESEARCH DESIGN AND METHODS centrifugation, and cultured as previously described (20). Prlr b Recombinant mouse prolactin (R&D Systems) was diluted Creation of the Floxed Allele, PRLRKO, and fi bMafBKO Mice in culture media to a nal concentration of 500 ng/ml. Culture media was changed daily. A targeting vector containing Prlr genomic DNA encompass- ing exons 4 through 9 were subcloned into plasmid PL253 Imaging containing a thymidine kinase cassette. Using recombineer- Microscopy was performed on a Zeiss AxioM1 Fluores- ing, loxP and FRT-neo-FRT-loxP cassettes were placed flank- cence microscope with AxioVision software (Carl Zeiss). ing exon 5. The targeting vector was electroporated into Confocal images were obtained using a Leica Sp2 micro- C57BL/6J embryonic stem cells and clones selected us- scope (Beckman Cell Sciences Imaging Facility; Leica ing G418; validated clones were injected into 129 blastocysts Microsystems). generating chimeric males (Stanford Transgenic Core). Germ- Quantifying b-Cell Mass and Proliferation Prlrf fi line transmission of allele was identi ed by brown fur After weighing, the pancreas was fixed, embedded in pups after crossing male chimeras with C57BL/6J females. optimal cutting temperature compound, and then frozen. Mouse tail genomic DNA was digested with NheI and South- Tissues were sectioned at 10-mm intervals using a Leica 9 fi ern blotting performed with a 5 external probe to con rm a 3050S Cryostat (Leica Microsystems). We immunostained fl correctly targeted allele. The FRT- anked neo cassette was tissue with anti-insulin antibody and DAPI and then an- FLP removed by crosses with eR mice (The Jackson Labora- alyzed sections separated by 200 mm. b-Cell mass was fl Prlrf/+ tory,BarHarbor,ME),generating oxed PRLR mice ( ), measured using ImageJ (National Institutes of Health) which were backcrossed with C57BL/6J mice (The Jackson to quantify insulin+ and total pancreas area in each section; Prlrf/+ Laboratory) for more than eight generations. mice b-cell area was the average of nine measured sections. The were crossed with mice with a transgene encoding Cre calculated b-cell mass = (b-cell area/total pancreas area) 3 RIP-Cre recombinase from rat insulin promoter elements ( ) (total pancreas weight). To measure proliferation, we RIP-Cre;Prlrf/+ (16). Subsequently, males were crossed with immunostained tissues using antibodies against insulin Prlrf/+ b PRLRf/f RIP-Cre females, generating PRLRKO ( ; )and and Ki-67 and the proportion of Ki-67+ b-cells calculated Prlrf/+ Prlrf/f RIP-Cre;Prlrf/+ RIP-Cre;Prlr+/+ littermate , , ,and as a percentage. At least 1,500 b-cells were counted for MafBf/f RIP-CreM controls. mice (17) were crossed with each animal; only clusters containing at least 20 b-cells mice (18) and backcrossed to B6J mice at least six gener- were counted. The total number of islets per mouse was ations (see Supplementary Table 1: genotyping primers). the sum of clusters counted in nine analyzed sections. Mouse Husbandry, Breeding, and Experimentation Antibodies used are listed in
Recommended publications
  • What Are Knockout Mice?
    Lecture 37 Knockout mice Lecture 29 Cloning and Expression vectors Lecture 30 Eukaryotic Protein Expression Systems –I Lecture 31 Eukaryotic Protein Expression Systems –II Lecture 32 Eukaryotic Protein Expression Systems –III Lecture 33 Human Gene Therapy Lecture 34 DNA Vaccines Lecture 35 Transgenic Animals Lecture 36 Transgenic Plants Lecture 37 Knockout Mice What are knockout mice? A knockout mouse is a mouse in which a specific gene has been inactivated or “knocked out” by replacing it or disrupting it with an artificial piece of DNA. The loss of gene activity often causes changes in a mouse's phenotype and thus provides valuable information on the function of the gene. Researchers who developed the technology for the creation of knockout mice won Nobel Prize in the year 2007 The Nobel Prize in Physiology or Medicine 2007 was awarded jointly to Mario R. Capecchi, Sir Martin J. Evans and Oliver Smithies "for their discoveries of principles for introducing specific gene modifications in mice by the use of embryonic stem cells". Mario R. Capecchi Sir Martin J. Evans Oliver Smithies The ability to delete or mutate any gene of interest in mice has transformed the landscape of mammalian biology research. Cultivation of embryonic stem (ES) cells – Martin Evans • Gene targeting – Oliver Smithies • Gene knockout – Mario Capecchi Gene correction by Oliver Smithies Targeted correction of a mutant HPRT gene in mouse ES cells. Nature 330:576-8, 1987 This modification of a chosen gene in pluripotent ES cells demonstrates the feasibility of this route to manipulating mammalian genomes in predetermined ways. -------------------------------------------------------------------------------------- Nature. 1985 Sep 19-25;317(6034):230-4.
    [Show full text]
  • The Human Genome Project Focus of the Human Genome Project
    TOOLS OF GENETIC RESEARCH THE HUMAN GENOME PROJECT FOCUS OF THE HUMAN GENOME PROJECT The primary work of the Human Genome Project has been to Francis S. Collins, M.D., Ph.D.; produce three main research tools that will allow investigators to and Leslie Fink identify genes involved in normal biology as well as in both rare and common diseases. These tools are known as positional cloning The Human Genome Project is an ambitious research effort aimed at deciphering the chemical makeup of the entire human (Collins 1992). These advanced techniques enable researchers to ge ne tic cod e (i.e. , the g enome). The primary wor k of the search for disease­linked genes directly in the genome without first having to identify the gene’s protein product or function. (See p ro j e c t i s t o d ev e lop t h r e e r e s e a r c h tool s t h a t w i ll a ll o w the article by Goate, pp. 217–220.) Since 1986, when researchers scientists to identify genes involved in both rare and common 2 diseases. Another project priority is to examine the ethical, first found the gene for chronic granulomatous disease through legal, and social implications of new genetic technologies and positional cloning, this technique has led to the isolation of consid­ to educate the public about these issues. Although it has been erably more than 40 disease­linked genes and will allow the identi­ in existence for less than 6 years, the Human Genome Project fication of many more genes in the future (table 1).
    [Show full text]
  • Generation of Mouse Conditional Knockout Alleles in One Step Using the I-GONAD Method
    Downloaded from genome.cshlp.org on September 29, 2021 - Published by Cold Spring Harbor Laboratory Press Method Generation of mouse conditional knockout alleles in one step using the i-GONAD method Renjie Shang,1,2 Haifeng Zhang,1 and Pengpeng Bi1,2 1Center for Molecular Medicine, University of Georgia, Athens, Georgia 30602, USA; 2Department of Genetics, University of Georgia, Athens, Georgia 30602, USA The Cre/loxP system is a powerful tool for gene function study in vivo. Regulated expression of Cre recombinase mediates precise deletion of genetic elements in a spatially– and temporally–controlled manner. Despite the robustness of this system, it requires a great amount of effort to create a conditional knockout model for each individual gene of interest where two loxP sites must be simultaneously inserted in cis. The current undertaking involves labor-intensive embryonic stem (ES) cell– based gene targeting and tedious micromanipulations of mouse embryos. The complexity of this workflow poses formida- ble technical challenges, thus limiting wider applications of conditional genetics. Here, we report an alternative approach to generate mouse loxP alleles by integrating a unique design of CRISPR donor with the new oviduct electroporation technique i-GONAD. Showing the potential and simplicity of this method, we created floxed alleles for five genes in one attempt with relatively low costs and a minimal equipment setup. In addition to the conditional alleles, constitutive knockout alleles were also obtained as byproducts of these experiments. Therefore, the wider applications of i-GONAD may promote gene func- tion studies using novel murine models. [Supplemental material is available for this article.] Our understanding of the genetic mechanisms of human diseases strains are readily available, generation of the loxP-flanked (floxed) has been largely expanded by loss-of-function studies using engi- alleles is challenging and labor-intensive due to the lack of an effi- neered mouse models.
    [Show full text]
  • Distress Regulates Different Pathways in the Brain of Common Carp: a Preliminary Study
    animals Communication Distress Regulates Different Pathways in the Brain of Common Carp: A Preliminary Study Alexander Burren and Constanze Pietsch * School of Agricultural, Forest and Food Sciences (HAFL), Applied University Berne (BFH), 3052 Zollikofen, Switzerland; [email protected] * Correspondence: [email protected] Simple Summary: The aquaculture sector provides for nearly half of the world’s seafood consump- tion, thanks to its large expansion over the last 30 years. Despite this intense growth, clear guidelines for responsible practices and animal wellbeing are lacking. Gene expression studies are a fundamen- tal tool for understanding welfare, but stress-markers in aquaculture fish species are poorly studied. In addition, the biostatistical analysis of gene expression data is not trivial, and this study applies different statistical methods in order to evaluate potential differences in the gene expression levels between control fish and fish acutely stressed by exposure to air. Abstract: In this study, a stress trial was conducted with common carp, one of the most important species in aquaculture worldwide, to identify relevant gene regulation pathways in different areas of the brain. Acute distress due to exposure to air significantly activated the expression of the immediate early gene c-fos in the telencephalon. In addition, evidence for regulation of the two corticotropin-releasing factor (crf ) genes in relation to their binding protein (corticotropin-releasing hormone-binding protein, crh-bp) is presented in this preliminary study. Inferences on the effects Citation: Burren, A.; Pietsch, C. of due to exposure to air were obtained by using point estimation, which allows the prediction of Distress Regulates Different a single value.
    [Show full text]
  • Generation of Knockout Mouse Models of Cyclin-Dependent Kinase Inhibitors by Engineered Nuclease-Mediated Genome Editing
    ISSN 1738-6055 (Print) ISSN 2233-7660 (Online) Lab Anim Res 2018: 34(4), 264-269 https://doi.org/10.5625/lar.2018.34.4.264 Generation of knockout mouse models of cyclin-dependent kinase inhibitors by engineered nuclease-mediated genome editing Bo Min Park, Jae-il Roh*, Jaehoon Lee*, Han-Woong Lee* Department of Biochemistry, College of Life Science & Biotechnology, Yonsei University, Seoul, Korea Cell cycle dysfunction can cause severe diseases, including neurodegenerative disease and cancer. Mutations in cyclin-dependent kinase inhibitors controlling the G1 phase of the cell cycle are prevalent in various cancers. Mice lacking the tumor suppressors p16Ink4a (Cdkn2a, cyclin-dependent kinase inhibitor 2a), p19Arf (an alternative reading frame product of Cdkn2a,), and p27Kip1 (Cdkn1b, cyclin-dependent kinase inhibitor 1b) result in malignant progression of epithelial cancers, sarcomas, and melanomas, respectively. Here, we generated knockout mouse models for each of these three cyclin-dependent kinase inhibitors using engineered nucleases. The p16Ink4a and p19Arf knockout mice were generated via transcription activator-like effector nucleases (TALENs), and p27Kip1 knockout mice via clustered regularly interspaced short palindromic repeats/CRISPR-associated nuclease 9 (CRISPR/Cas9). These gene editing technologies were targeted to the first exon of each gene, to induce frameshifts producing premature termination codons. Unlike preexisting embryonic stem cell-based knockout mice, our mouse models are free from selectable markers or other external gene insertions, permitting more precise study of cell cycle-related diseases without confounding influences of foreign DNA. Keywords: TALEN, CRISPR/Cas9, cyclin-dependent kinase inhibitor Received 20 October 2018; Revised version received 7 December 2018; Accepted 8 December 2018 The cell cycle constitutes a series of events required proteins can cause severe disease [16,25,33].
    [Show full text]
  • Generating Mouse Models for Biomedical Research: Technological Advances Channabasavaiah B
    © 2019. Published by The Company of Biologists Ltd | Disease Models & Mechanisms (2019) 12, dmm029462. doi:10.1242/dmm.029462 AT A GLANCE Generating mouse models for biomedical research: technological advances Channabasavaiah B. Gurumurthy1,2 and Kevin C. Kent Lloyd3,4,* ABSTRACT recombination in embryonic stem cells has given way to more refined Over the past decade, new methods and procedures have been methods that enable allele-specific manipulation in zygotes. We also developed to generate geneticallyengineered mouse models of human highlight advances in the use of programmable endonucleases that disease. This At a Glance article highlights several recent technical have greatly increased the feasibility and ease of editing the mouse advances in mouse genome manipulation that have transformed genome. Together, these and other technologies provide researchers our ability to manipulate and study gene expression in the mouse. with the molecular tools to functionally annotate the mouse genome We discuss how conventional gene targeting by homologous with greater fidelity and specificity, as well as to generate new mouse models using faster, simpler and less costly techniques. 1Developmental Neuroscience, Munroe Meyer Institute for Genetics and KEY WORDS: CRISPR, Genome editing, Mouse, Mutagenesis Rehabilitation, University of Nebraska Medical Center, Omaha, NE 68106-5915, USA. 2Mouse Genome Engineering Core Facility, Vice Chancellor for Research Office, University of Nebraska Medical Center, Omaha, NE 68106-5915, USA. Introduction 3Department
    [Show full text]
  • Relaxin: a Missing Link in the Pathomechanisms of Systemic Lupus Erythematosus?
    http://informahealthcare.com/mor ISSN 1439-7595 (print), 1439-7609 (online) Mod Rheumatol, 2014; 24(4): 547–551 © 2014 Japan College of Rheumatology DOI: 10.3109/14397595.2013.844297 REVIEW ARTICLE Relaxin: A missing link in the pathomechanisms of Systemic Lupus Erythematosus? Madhusoothanan Bhagavathi Perumal1 and Saranya Dhanasekaran2 1 Queensland Brain Institute, The University of Queensland, Brisbane, Australia and 2 Chhatrapati Shahuji Maharaj Hospital, Lucknow, India Downloaded from https://academic.oup.com/mr/article/24/4/547/6303646 by guest on 01 October 2021 Abstract Keywords Systemic Lupus Erythematosus (SLE) is an autoimmune rheumatic disease which predominantly Autoimmunity , Endometrium , Macrophages , aff ects women of reproductive age. Despite signifi cant progress in recent years to elucidate Relaxin , Systemic Lupus Erythematosus many potential mechanisms involved in the generation of autoimmunity the factors behind the high incidence among women, the relapsing – remitting clinical course and pregnancy-related History complications in SLE remain unclear. In this review, we hypothesize a potential role for uterine Received 5 February 2013 endometrium through its production of relaxin, a peptide hormone, as a “ missing-link ” to explain Accepted 15 May 2013 this female predominance, variable clinical course and obstetric complications operating in SLE. Published online 16 October 2013 Background In contrast, M2 macrophages are important in tissue repair and wound healing. They express high levels of anti-infl ammatory Systemic Lupus Erythematosus (SLE) is an autoimmune disease cytokines (such as IL10) as well as growth factors such as vascular which can aff ect any part of the body leading to a myriad of clini- endothelial growth factor (VEGF) and basic Fibroblast growth fac- cal manifestations.
    [Show full text]
  • Double-Strand Break Repair Pathways in Dna Structure-Induced Genetic Instability
    The Texas Medical Center Library DigitalCommons@TMC The University of Texas MD Anderson Cancer Center UTHealth Graduate School of The University of Texas MD Anderson Cancer Biomedical Sciences Dissertations and Theses Center UTHealth Graduate School of (Open Access) Biomedical Sciences 8-2010 DOUBLE-STRAND BREAK REPAIR PATHWAYS IN DNA STRUCTURE-INDUCED GENETIC INSTABILITY Diem T. Kha Follow this and additional works at: https://digitalcommons.library.tmc.edu/utgsbs_dissertations Part of the Laboratory and Basic Science Research Commons Recommended Citation Kha, Diem T., "DOUBLE-STRAND BREAK REPAIR PATHWAYS IN DNA STRUCTURE-INDUCED GENETIC INSTABILITY" (2010). The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences Dissertations and Theses (Open Access). 76. https://digitalcommons.library.tmc.edu/utgsbs_dissertations/76 This Thesis (MS) is brought to you for free and open access by the The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences at DigitalCommons@TMC. It has been accepted for inclusion in The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences Dissertations and Theses (Open Access) by an authorized administrator of DigitalCommons@TMC. For more information, please contact [email protected]. DOUBLE-STRAND BREAK REPAIR PATHWAYS IN DNA STRUCTURE-INDUCED GENETIC INSTABILITY BY Diem Thi Kha, Bachelor of Science APPROVED: ______________________________ Karen M. Vasquez, Ph.D., Supervisory ______________________________
    [Show full text]
  • Supplementary Table 2
    Supplementary Table 2. Differentially Expressed Genes following Sham treatment relative to Untreated Controls Fold Change Accession Name Symbol 3 h 12 h NM_013121 CD28 antigen Cd28 12.82 BG665360 FMS-like tyrosine kinase 1 Flt1 9.63 NM_012701 Adrenergic receptor, beta 1 Adrb1 8.24 0.46 U20796 Nuclear receptor subfamily 1, group D, member 2 Nr1d2 7.22 NM_017116 Calpain 2 Capn2 6.41 BE097282 Guanine nucleotide binding protein, alpha 12 Gna12 6.21 NM_053328 Basic helix-loop-helix domain containing, class B2 Bhlhb2 5.79 NM_053831 Guanylate cyclase 2f Gucy2f 5.71 AW251703 Tumor necrosis factor receptor superfamily, member 12a Tnfrsf12a 5.57 NM_021691 Twist homolog 2 (Drosophila) Twist2 5.42 NM_133550 Fc receptor, IgE, low affinity II, alpha polypeptide Fcer2a 4.93 NM_031120 Signal sequence receptor, gamma Ssr3 4.84 NM_053544 Secreted frizzled-related protein 4 Sfrp4 4.73 NM_053910 Pleckstrin homology, Sec7 and coiled/coil domains 1 Pscd1 4.69 BE113233 Suppressor of cytokine signaling 2 Socs2 4.68 NM_053949 Potassium voltage-gated channel, subfamily H (eag- Kcnh2 4.60 related), member 2 NM_017305 Glutamate cysteine ligase, modifier subunit Gclm 4.59 NM_017309 Protein phospatase 3, regulatory subunit B, alpha Ppp3r1 4.54 isoform,type 1 NM_012765 5-hydroxytryptamine (serotonin) receptor 2C Htr2c 4.46 NM_017218 V-erb-b2 erythroblastic leukemia viral oncogene homolog Erbb3 4.42 3 (avian) AW918369 Zinc finger protein 191 Zfp191 4.38 NM_031034 Guanine nucleotide binding protein, alpha 12 Gna12 4.38 NM_017020 Interleukin 6 receptor Il6r 4.37 AJ002942
    [Show full text]
  • Galanin and Prolactin in 2 Cichlids 2021.Pdf
    General and Comparative Endocrinology 309 (2021) 113785 Contents lists available at ScienceDirect General and Comparative Endocrinology journal homepage: www.elsevier.com/locate/ygcen Research paper Galanin and prolactin expression in relation to parental care in two sympatric cichlid species from Lake Tanganyika Filipa Cunha-Saraiva a,*, Rute S.T. Martins b, Deborah M. Power b, Sigal Balshine c,1, Franziska C. Schaedelin a,1 a Konrad Lorenz Institute of Ethology, Department of Interdisciplinary Life Sciences, University of Veterinary Medicine Vienna, Austria b Centre of Marine Sciences (CCMAR), University of Algarve, Faro, Portugal c Aquatic Behavioural Ecology Laboratory, Department of Psychology, Neuroscience, & Behaviour, McMaster University, Ontario, Canada ARTICLE INFO ABSTRACT Keywords: Our understanding of the hormonal mechanisms underlying parental care mainly stems from research on species Gene expression with uniparental care. Far less is known about the physiological changes underlying motherhood and fatherhood Breeding cycle in biparental caring species. Here, using two biparental caring cichlid species (Neolamprologus caudopunctatus and Neurogenomic mechanisms Neolamprologus pulcher), we explored the relative gene-expression levels of two genes implicated in the control of Cooperative breeding parental care, galanin (gal) and prolactin (prl). We investigated whole brain gene expression levels in both, male Biparental care Neolamprologus caudopunctatus and female caring parents, as well as in non-caring individuals of both species. Caring males had higher prl and Neolamprologus pulcher gal mRNA levels compared to caring females in both fsh species. Expression of gal was highest when young were mobile and the need for parental defense was greatest and gal was lowest during the more stationary egg tending phase in N.
    [Show full text]
  • Manipulating the Mouse Genome Using Recombineering
    e in G net ts ic n E e n Biswas and Sharan, Adv Genet Eng 2013, 2:2 g m i e n c e e n DOI: 10.4172/2169-0111.1000108 r a i v n d g A Advancements in Genetic Engineering ISSN: 2169-0111 Review Article Open Access Manipulating the Mouse Genome Using Recombineering Kajal Biswas and Shyam K Sharan* Mouse Cancer Genetics Program, Center for Cancer Research, National Cancer Institute at Frederick, Frederick, Maryland 21702, USA Abstract Genetically engineered mouse models are indispensable for understanding the biological function of genes, understanding the genetic basis of human diseases, and for preclinical testing of novel therapies. Generation of such mouse models has been possible because of our ability to manipulate the mouse genome. Recombineering is a highly efficient, recombination-based method of genetic engineering that has revolutionized our ability to generate mouse models. Since recombineering technology is not dependent on the availability of restriction enzyme recognition sites, it allows us to modify the genome with great precision. It requires homology arms as short as 40 bases for recombination, which makes it relatively easy to generate targeting constructs to insert, change, or delete either a single nucleotide or a DNA fragment several kb in size; insert selectable markers or reporter genes; or add epitope tags to any gene of interest. In this review, we focus on the development of recombineering technology and its application to the generation of genetically engineered mouse models. High-throughput generation of gene targeting vectors, used to construct knockout alleles in mouse embryonic stem cells, is now feasible because of this technology.
    [Show full text]
  • Embryo-Based Large Fragment Knock-In in Mammals: Why, How and What’S Next
    G C A T T A C G G C A T genes Review Embryo-Based Large Fragment Knock-in in Mammals: Why, How and What’s Next Steven Erwood 1,2 and Bin Gu 3,* 1 Program in in Genetics and Genome Biology, Hospital for Sick Children, Toronto, ON M5G 0A4, Canada; [email protected] 2 Department of Molecular Genetics, University of Toronto, Toronto, ON M5S 1A8, Canada 3 Program in Developmental and Stem Cell Biology, Hospital for Sick Children, Toronto, ON M5G 0A4, Canada * Correspondence: [email protected]; Tel.: +647-702-9608; Fax: 416-813-6382 Received: 31 December 2019; Accepted: 26 January 2020; Published: 29 January 2020 Abstract: Endonuclease-mediated genome editing technologies, most notably CRISPR/Cas9, have revolutionized animal genetics by allowing for precise genome editing directly through embryo manipulations. As endonuclease-mediated model generation became commonplace, large fragment knock-in remained one of the most challenging types of genetic modification. Due to their unique value in biological and biomedical research, however, a diverse range of technological innovations have been developed to achieve efficient large fragment knock-in in mammalian animal model generation, with a particular focus on mice. Here, we first discuss some examples that illustrate the importance of large fragment knock-in animal models and then detail a subset of the recent technological advancements that have allowed for efficient large fragment knock-in. Finally, we envision the future development of even larger fragment knock-ins performed in even larger animal models, the next step in expanding the potential of large fragment knock-in in animal models.
    [Show full text]